Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-21-082064

Options or other derivatives

  • Interim CEO & General Counsel acquired 173,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2021-06-14 Grant or award · Stock Option (right to buy) +100,000 100,000 D: show line 1 in the form
Vogt Frederick G Interim CEO & General Counsel 2021-06-14 Grant or award · Stock Option (right to buy) +73,900 73,900 D: show line 2 in the form
Loading xslF345X03/tm2119923-1_4seq1.xml…